vs
Side-by-side financial comparison of CORVEL CORP (CRVL) and IMAX CORP (IMAX). Click either name above to swap in a different company.
CORVEL CORP is the larger business by last-quarter revenue ($235.6M vs $125.2M, roughly 1.9× IMAX CORP). CORVEL CORP runs the higher net margin — 10.3% vs 0.5%, a 9.8% gap on every dollar of revenue. On growth, IMAX CORP posted the faster year-over-year revenue change (35.1% vs 3.4%). CORVEL CORP produced more free cash flow last quarter ($35.2M vs $28.0M). Over the past eight quarters, IMAX CORP's revenue compounded faster (25.8% CAGR vs 6.6%).
Corvel Corp is a U.S.-headquartered provider of integrated workers’ compensation, healthcare management, and risk mitigation solutions. It serves insurance carriers, self-insured employers, and public sector clients, delivering services to control healthcare costs, improve care outcomes, and optimize administrative operations.
IMAX Corporation is a Canadian production theatre company which designs and manufactures IMAX cameras and projection systems as well as performing film development, production, post-production and distribution to IMAX-affiliated theatres worldwide. Founded in Montreal in 1967, it has headquarters in the Toronto area, and operations in New York City and Los Angeles.
CRVL vs IMAX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $235.6M | $125.2M |
| Net Profit | $24.2M | $637.0K |
| Gross Margin | 23.3% | 57.6% |
| Operating Margin | 13.7% | 19.3% |
| Net Margin | 10.3% | 0.5% |
| Revenue YoY | 3.4% | 35.1% |
| Net Profit YoY | 1.7% | -88.0% |
| EPS (diluted) | $0.47 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $235.6M | $125.2M | ||
| Q3 25 | $239.6M | $106.7M | ||
| Q2 25 | $234.7M | $91.7M | ||
| Q1 25 | $231.5M | $86.7M | ||
| Q4 24 | $228.0M | $92.7M | ||
| Q3 24 | $224.4M | $91.5M | ||
| Q2 24 | $211.7M | $89.0M | ||
| Q1 24 | $207.2M | $79.1M |
| Q4 25 | $24.2M | $637.0K | ||
| Q3 25 | $27.9M | $20.7M | ||
| Q2 25 | $27.2M | $11.3M | ||
| Q1 25 | $26.4M | $2.3M | ||
| Q4 24 | $23.8M | $5.3M | ||
| Q3 24 | $23.4M | $13.9M | ||
| Q2 24 | $21.6M | $3.6M | ||
| Q1 24 | $19.5M | $3.3M |
| Q4 25 | 23.3% | 57.6% | ||
| Q3 25 | 24.3% | 63.1% | ||
| Q2 25 | 24.2% | 58.5% | ||
| Q1 25 | 25.0% | 61.4% | ||
| Q4 24 | 23.2% | 52.2% | ||
| Q3 24 | 22.6% | 55.8% | ||
| Q2 24 | 22.7% | 49.4% | ||
| Q1 24 | 20.9% | 59.3% |
| Q4 25 | 13.7% | 19.3% | ||
| Q3 25 | 15.0% | 27.2% | ||
| Q2 25 | 15.0% | 15.6% | ||
| Q1 25 | 14.4% | 19.3% | ||
| Q4 24 | 13.5% | 10.3% | ||
| Q3 24 | 12.8% | 21.2% | ||
| Q2 24 | 13.2% | 3.2% | ||
| Q1 24 | 10.9% | 15.3% |
| Q4 25 | 10.3% | 0.5% | ||
| Q3 25 | 11.6% | 19.4% | ||
| Q2 25 | 11.6% | 12.3% | ||
| Q1 25 | 11.4% | 2.7% | ||
| Q4 24 | 10.4% | 5.7% | ||
| Q3 24 | 10.4% | 15.2% | ||
| Q2 24 | 10.2% | 4.0% | ||
| Q1 24 | 9.4% | 4.1% |
| Q4 25 | $0.47 | $0.02 | ||
| Q3 25 | $0.54 | $0.37 | ||
| Q2 25 | $0.52 | $0.20 | ||
| Q1 25 | $-1.23 | $0.04 | ||
| Q4 24 | $0.46 | $0.09 | ||
| Q3 24 | $1.35 | $0.26 | ||
| Q2 24 | $1.25 | $0.07 | ||
| Q1 24 | $1.12 | $0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $230.0M | $151.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $375.7M | $337.9M |
| Total Assets | $644.8M | $894.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $230.0M | $151.2M | ||
| Q3 25 | $207.5M | $143.1M | ||
| Q2 25 | $202.0M | $109.3M | ||
| Q1 25 | $170.6M | $97.1M | ||
| Q4 24 | $162.9M | $100.6M | ||
| Q3 24 | $138.3M | $104.5M | ||
| Q2 24 | $131.9M | $91.6M | ||
| Q1 24 | $105.6M | $81.0M |
| Q4 25 | $375.7M | $337.9M | ||
| Q3 25 | $362.8M | $349.5M | ||
| Q2 25 | $342.5M | $320.4M | ||
| Q1 25 | $322.0M | $299.5M | ||
| Q4 24 | $300.9M | $299.5M | ||
| Q3 24 | $282.8M | $289.4M | ||
| Q2 24 | $263.9M | $267.2M | ||
| Q1 24 | $247.6M | $258.8M |
| Q4 25 | $644.8M | $894.0M | ||
| Q3 25 | $611.7M | $889.6M | ||
| Q2 25 | $597.4M | $868.6M | ||
| Q1 25 | $546.0M | $848.3M | ||
| Q4 24 | $538.8M | $830.4M | ||
| Q3 24 | $518.6M | $847.6M | ||
| Q2 24 | $486.2M | $827.4M | ||
| Q1 24 | $454.7M | $824.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $46.1M | $29.4M |
| Free Cash FlowOCF − Capex | $35.2M | $28.0M |
| FCF MarginFCF / Revenue | 14.9% | 22.3% |
| Capex IntensityCapex / Revenue | 4.7% | 1.1% |
| Cash ConversionOCF / Net Profit | 1.91× | 46.11× |
| TTM Free Cash FlowTrailing 4 quarters | $104.3M | $118.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $46.1M | $29.4M | ||
| Q3 25 | $25.0M | $67.5M | ||
| Q2 25 | $55.0M | $23.2M | ||
| Q1 25 | $22.9M | $7.0M | ||
| Q4 24 | $41.6M | $11.5M | ||
| Q3 24 | $22.3M | $35.3M | ||
| Q2 24 | $40.4M | $35.0M | ||
| Q1 24 | $15.2M | $-11.0M |
| Q4 25 | $35.2M | $28.0M | ||
| Q3 25 | $15.3M | $64.8M | ||
| Q2 25 | $39.5M | $20.9M | ||
| Q1 25 | $14.3M | $5.3M | ||
| Q4 24 | $32.1M | $6.9M | ||
| Q3 24 | $12.4M | $34.2M | ||
| Q2 24 | $32.8M | $33.5M | ||
| Q1 24 | $5.2M | $-12.1M |
| Q4 25 | 14.9% | 22.3% | ||
| Q3 25 | 6.4% | 60.7% | ||
| Q2 25 | 16.8% | 22.8% | ||
| Q1 25 | 6.2% | 6.1% | ||
| Q4 24 | 14.1% | 7.4% | ||
| Q3 24 | 5.5% | 37.3% | ||
| Q2 24 | 15.5% | 37.6% | ||
| Q1 24 | 2.5% | -15.3% |
| Q4 25 | 4.7% | 1.1% | ||
| Q3 25 | 4.1% | 2.6% | ||
| Q2 25 | 6.6% | 2.6% | ||
| Q1 25 | 3.7% | 1.9% | ||
| Q4 24 | 4.2% | 5.0% | ||
| Q3 24 | 4.4% | 1.2% | ||
| Q2 24 | 3.6% | 1.8% | ||
| Q1 24 | 4.8% | 1.4% |
| Q4 25 | 1.91× | 46.11× | ||
| Q3 25 | 0.90× | 3.27× | ||
| Q2 25 | 2.02× | 2.06× | ||
| Q1 25 | 0.87× | 2.99× | ||
| Q4 24 | 1.75× | 2.16× | ||
| Q3 24 | 0.95× | 2.54× | ||
| Q2 24 | 1.87× | 9.78× | ||
| Q1 24 | 0.78× | -3.35× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CRVL
| Patient Management Services | $146.1M | 62% |
| Network Solutions Services | $89.6M | 38% |
IMAX
| Technology Sales | $46.6M | 37% |
| Image Enhancement And Maintenance Services | $38.1M | 30% |
| Joint Revenue Sharing Arrangement | $20.4M | 16% |
| Maintenance | $16.3M | 13% |
| Finance Income | $2.8M | 2% |
| Other Content Solutions | $1.6M | 1% |
